PARTNERSHIP OPPORTUNITIES

Explore Other Related Events

Hanson Wade is committed to bringing the cell and gene therapy spaces bespoke conferences catering for every niche, with the aim of getting better drugs to patients faster. Take a look at our related events below to find out more about our tailored conferences, designed to put you in the room with decision makers from both leading and emerging companies in these growing spaces.

Screenshot-2025-01-30-152327-landscape-8c757b2b9f732971548b59317ee3202d-q4rlz0w1e7xp
Screenshot-2025-01-12-221007-landscape-e3891df1e79628fcd10c5dd76efdeb67-odz5skxlbi8n

As an increasing number of genetic therapies advance through the development stages, companies are recognizing the importance of effective patient engagement in the success of gene therapy initiatives.

Gene therapy companies are seeking partnerships with organizations that not only understand but actively integrate patient-centric values within gene therapy services. Such collaborations are instrumental in bolstering and streamlining the development pipelines of these companies.

By aligning with us, you gain a distinctive platform to showcase how your services resonate with gene therapy companies aiming to incorporate the patient voice into clinical trials and gene therapy development.

Reach out to us today to discover more about how we can collaboratively forge a tailored partnership to support your business development objectives.

What do the Experts need?

  • Clinical CROs – There is an increasing need for expertize in patient recruitment, retention and engagement as more trials progress into the clinic. Seize this opportunity to showcase improve communication, education, and support for patients enrolled in gene therapy trials, ultimately leading to better engagement.
  • Consultants - Ensuring patient engagement strategies are ethically sound adhere to guidelines related to informed consent, patient autonomy, and protection of vulnerable populations is vital. Take this opportunity to demonstrate how you can assess potential risk and develop clear communication about gene therapies.
  • Medical Communications - Translating technical information into patient-friendly materials, such as brochures, videos, and websites, making it more accessible for potential trial participants can be a challenge. Demonstrate how you assist gene therapy companies in crafting clear and compelling messages about the gene therapy, trial objectives, and facilitating better engagement with patients.
  • Patient Support Platforms - Establishing a comprehensive and technology-driven approach to support trial participants is vital to enhance communication, provide educational resources, offer real-time support, and contribute to the overall success of gene therapy trials by fostering a positive and engaged patient experience.

And so much more!

Why Partner in 2025?

HW221219 Gene Therapy Patient Engagement 2023 logo

Thought Leadership

Present on the main agenda with Krystal Biotech, Ultragenyx Pharmaceutical & Regeneron Pharmaceuticals to demonstrate your expertize and position yourself as the market leader

HW221219 Gene Therapy Patient Engagement 2023 logo

Lead Generation

Secure unmissable face time with key decision makers through our dedicated speed networking and pre-organized 1-2-1 meetings with key decision makers

HW221219 Gene Therapy Patient Engagement 2023 logo

Elevate Brand Awareness

Increase market share through advertising during pre-conference and main conference days

HW221219 Gene Therapy Patient Engagement 2023 logo

Showcase your work

To key decision makers, including CMOs, and Directors of Patient Advocacy and Engagement. Give potential customers hands-on insight into your resources in the exhibition room